Crispr Therapeutics Ag (CRSP)

Cash & Equivalents

$291.34M

Quarterly · Period ending: · USD

CRSP logo

CRSP Cash & Equivalents

Latest reported$355.19M
CRSP FY Cash & Equivalents ($945.00K → $355.19M)
High-resolution chart · PNG

CRSP cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
355,188,000
298,257,000
389,477,000
211,885,000
923,031,000
1,168,620,000
943,771,000
456,649,000
239,758,000
315,520,000
155,961,000
945,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.